However, breast cancer subtype can be determinant of this shift in T cell differentiation, given that HER2− and hormone receptor-positive patients harbor a higher proportion of naïve and TCM (central memory subset) than more mature CD8+ T cell populations [52,78], while the opposite is seen in HER2+ patients [52]. Here, ERBB2 is linked to breast cancer.